45 related articles for article (PubMed ID: 18185524)
1. Cooperative genetic defects in TLX3 rearranged pediatric T-ALL.
Van Vlierberghe P; Homminga I; Zuurbier L; Gladdines-Buijs J; van Wering ER; Horstmann M; Beverloo HB; Pieters R; Meijerink JP
Leukemia; 2008 Apr; 22(4):762-70. PubMed ID: 18185524
[TBL] [Abstract][Full Text] [Related]
2. T/myeloid mixed phenotype acute leukaemia harbouring TLX3::BCL11B with TLX3 activation.
Botten GA; Zhang Y; Fuda F; Koduru P; Weinberg OK; Slone TL; Zheng R; Dickerson KE; Gagan JR; Chen W
Br J Haematol; 2024 Feb; ():. PubMed ID: 38385580
[TBL] [Abstract][Full Text] [Related]
3. Genomic imbalances analysis provides new insight into prognostic factors in adult and pediatric T-ALL.
Balducci E; Simonin M; Duployez N; Steimlé T; Dourthe ME; Villarese P; Ducassou S; Arnoux I; Cayuela JM; Balsat M; Courtois L; Andrieu GP; Touzart A; Huguet F; Petit A; Ifrah N; Dombret H; Baruchel A; Macintyre EA; Preudhomme C; Boissel N; Asnafi V
Blood; 2024 Mar; ():. PubMed ID: 38518104
[TBL] [Abstract][Full Text] [Related]
4. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
[TBL] [Abstract][Full Text] [Related]
5. Linking genomic lesions with minimal residual disease improves prognostic stratification in children with T-cell acute lymphoblastic leukaemia.
La Starza R; Lettieri A; Pierini V; Nofrini V; Gorello P; Songia S; Crescenzi B; Te Kronnie G; Giordan M; Leszl A; Valsecchi MG; Aversa F; Basso G; Biondi A; Conter V; Cazzaniga G; Mecucci C
Leuk Res; 2013 Aug; 37(8):928-35. PubMed ID: 23735857
[TBL] [Abstract][Full Text] [Related]
6. WT1 mutations in T-ALL.
Tosello V; Mansour MR; Barnes K; Paganin M; Sulis ML; Jenkinson S; Allen CG; Gale RE; Linch DC; Palomero T; Real P; Murty V; Yao X; Richards SM; Goldstone A; Rowe J; Basso G; Wiernik PH; Paietta E; Pieters R; Horstmann M; Meijerink JP; Ferrando AA
Blood; 2009 Jul; 114(5):1038-45. PubMed ID: 19494353
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of SHIP1 in T-cell acute lymphoblastic leukemia due to mutation and extensive alternative splicing.
Lo TC; Barnhill LM; Kim Y; Nakae EA; Yu AL; Diccianni MB
Leuk Res; 2009 Nov; 33(11):1562-6. PubMed ID: 19473701
[TBL] [Abstract][Full Text] [Related]
8. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia.
Coustan-Smith E; Mullighan CG; Onciu M; Behm FG; Raimondi SC; Pei D; Cheng C; Su X; Rubnitz JE; Basso G; Biondi A; Pui CH; Downing JR; Campana D
Lancet Oncol; 2009 Feb; 10(2):147-56. PubMed ID: 19147408
[TBL] [Abstract][Full Text] [Related]
9. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.
Mullighan CG; Su X; Zhang J; Radtke I; Phillips LA; Miller CB; Ma J; Liu W; Cheng C; Schulman BA; Harvey RC; Chen IM; Clifford RJ; Carroll WL; Reaman G; Bowman WP; Devidas M; Gerhard DS; Yang W; Relling MV; Shurtleff SA; Campana D; Borowitz MJ; Pui CH; Smith M; Hunger SP; Willman CL; Downing JR;
N Engl J Med; 2009 Jan; 360(5):470-80. PubMed ID: 19129520
[TBL] [Abstract][Full Text] [Related]
10. Structural variation cooperates with permissive chromatin to control enhancer hijacking-mediated oncogenic transcription.
Botten GA; Zhang Y; Dudnyk K; Kim YJ; Liu X; Sanders JT; Imanci A; Droin N; Cao H; Kaphle P; Dickerson KE; Kumar KR; Chen M; Chen W; Solary E; Ly P; Zhou J; Xu J
Blood; 2023 Jul; 142(4):336-351. PubMed ID: 36947815
[TBL] [Abstract][Full Text] [Related]
11. TAL1 activation in T-cell acute lymphoblastic leukemia: a novel oncogenic 3' neo-enhancer.
Smith C; Goyal A; Weichenhan D; Allemand E; Mayakonda A; Toprak U; Riedel A; Balducci E; Manojkumar M; Pejkovska A; Mücke O; Sollier E; Bakr A; Breuer K; Lutsik P; Hermine O; Spicuglia S; Asnafi V; Plass C; Touzart A
Haematologica; 2023 May; 108(5):1259-1271. PubMed ID: 36632736
[TBL] [Abstract][Full Text] [Related]
12. Enhancer Hijacking Drives Oncogenic
Montefiori LE; Bendig S; Gu Z; Chen X; Pölönen P; Ma X; Murison A; Zeng A; Garcia-Prat L; Dickerson K; Iacobucci I; Abdelhamed S; Hiltenbrand R; Mead PE; Mehr CM; Xu B; Cheng Z; Chang TC; Westover T; Ma J; Stengel A; Kimura S; Qu C; Valentine MB; Rashkovan M; Luger S; Litzow MR; Rowe JM; den Boer ML; Wang V; Yin J; Kornblau SM; Hunger SP; Loh ML; Pui CH; Yang W; Crews KR; Roberts KG; Yang JJ; Relling MV; Evans WE; Stock W; Paietta EM; Ferrando AA; Zhang J; Kern W; Haferlach T; Wu G; Dick JE; Klco JM; Haferlach C; Mullighan CG
Cancer Discov; 2021 Nov; 11(11):2846-2867. PubMed ID: 34103329
[TBL] [Abstract][Full Text] [Related]
13. Bcl11b/Ctip2 in Skin, Tooth, and Craniofacial System.
Daher MT; Bausero P; Agbulut O; Li Z; Parlakian A
Front Cell Dev Biol; 2020; 8():581674. PubMed ID: 33363142
[TBL] [Abstract][Full Text] [Related]
14. RAS and TP53 can predict survival in adults with T-cell lymphoblastic leukemia treated with hyper-CVAD.
Sakhdari A; Thakral B; Loghavi S; Kanagal-Shamanna R; Yin CC; Zuo Z; Routbort MJ; Luthra R; Medeiros LJ; Wang SA; Patel KP; Ok CY
Cancer Med; 2020 Feb; 9(3):849-858. PubMed ID: 31804006
[TBL] [Abstract][Full Text] [Related]
15. Homeobox protein TLX3 activates miR-125b expression to promote T-cell acute lymphoblastic leukemia.
Renou L; Boelle PY; Deswarte C; Spicuglia S; Benyoucef A; Calvo J; Uzan B; Belhocine M; Cieslak A; Landman-Parker J; Baruchel A; Asnafi V; Pflumio F; Ballerini P; Naguibneva I
Blood Adv; 2017 May; 1(12):733-747. PubMed ID: 29296717
[TBL] [Abstract][Full Text] [Related]
16.
Bordin F; Piovan E; Masiero E; Ambesi-Impiombato A; Minuzzo S; Bertorelle R; Sacchetto V; Pilotto G; Basso G; Zanovello P; Amadori A; Tosello V
Haematologica; 2018 Feb; 103(2):266-277. PubMed ID: 29170254
[TBL] [Abstract][Full Text] [Related]
17. FBXW7 negatively regulates ENO1 expression and function in colorectal cancer.
Zhan P; Wang Y; Zhao S; Liu C; Wang Y; Wen M; Mao JH; Wei G; Zhang P
Lab Invest; 2015 Sep; 95(9):995-1004. PubMed ID: 26097998
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of transcriptome variation uncovers known and novel driver events in T-cell acute lymphoblastic leukemia.
Atak ZK; Gianfelici V; Hulselmans G; De Keersmaecker K; Devasia AG; Geerdens E; Mentens N; Chiaretti S; Durinck K; Uyttebroeck A; Vandenberghe P; Wlodarska I; Cloos J; Foà R; Speleman F; Cools J; Aerts S
PLoS Genet; 2013; 9(12):e1003997. PubMed ID: 24367274
[TBL] [Abstract][Full Text] [Related]
19. Acute lymphoblastic leukaemia.
Inaba H; Greaves M; Mullighan CG
Lancet; 2013 Jun; 381(9881):1943-55. PubMed ID: 23523389
[TBL] [Abstract][Full Text] [Related]
20. Genomic profiling of B-progenitor acute lymphoblastic leukemia.
Mullighan CG
Best Pract Res Clin Haematol; 2011 Dec; 24(4):489-503. PubMed ID: 22127311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
